Key Points
- Billiontoone CTO David Tsao sold 20,000 shares at an average price of $98.77, generating approximately $1.98 million. The Rule 10b5-1 transaction reduced his ownership by 95.24%, leaving him with 1,000 shares.
- Billiontoone recently reported quarterly earnings of $0.15 per share, matching analyst expectations, with revenue of $109.45 million. The stock opened at $98.77, with a market capitalization of approximately $4.66 billion.
- Analyst sentiment is mixed but leans positive: seven analysts rate the stock a Buy, two rate it Hold, and two rate it Sell. The consensus rating is Hold, with an average price target of $125.88.
Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) SVP Bosch John Roderick Ten sold 1,416 shares of the stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $97.54, for a total transaction of $138,116.64. Following the completion of the transaction, the senior vice president directly owned 25,051 shares of the company's stock, valued at approximately $2,443,474.54. The trade was a 5.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Bosch John Roderick Ten also recently made the following trade(s):
- On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total transaction of $141,700.00.
- On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total value of $131,582.62.
- On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total value of $169,920.00.
- On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The stock was sold at an average price of $101.47, for a total value of $287,363.04.
Billiontoone Price Performance
Billiontoone stock opened at $98.77 on Friday. The stock has a 50-day moving average price of $111.64 and a two-hundred day moving average price of $95.81. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44. The company has a market capitalization of $4.66 billion and a PE ratio of 141.10. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17.
Billiontoone (NASDAQ:BLLN - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting the consensus estimate of $0.15. The company had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. Analysts expect that Billiontoone, Inc. will post 0.83 EPS for the current year.
Hedge Funds Weigh In On Billiontoone
Hedge funds and other institutional investors have recently bought and sold shares of the company. Integrated Wealth Concepts LLC bought a new stake in Billiontoone during the second quarter valued at $29,000. Rossby Financial LCC bought a new position in shares of Billiontoone in the 4th quarter worth about $25,000. MCF Advisors LLC raised its position in shares of Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company's stock worth $54,000 after acquiring an additional 344 shares in the last quarter. Wells Fargo & Company MN acquired a new position in shares of Billiontoone in the 4th quarter valued at about $76,000. Finally, Smartleaf Asset Management LLC acquired a new position in shares of Billiontoone in the 4th quarter valued at about $80,000.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on BLLN. Canaccord Genuity Group started coverage on shares of Billiontoone in a research note on Wednesday, September 2nd. They issued a "buy" rating and a $120.00 price objective on the stock. JPMorgan Chase & Co. cut their target price on Billiontoone from $145.00 to $130.00 and set an "overweight" rating on the stock in a report on Thursday, August 6th. BTIG Research reduced their price target on Billiontoone from $142.00 to $130.00 and set a "buy" rating on the stock in a research report on Thursday, August 6th. Guggenheim began coverage on Billiontoone in a research note on Monday, June 29th. They issued a "buy" rating and a $125.00 price target for the company. Finally, Zacks Research lowered Billiontoone from a "hold" rating to a "strong sell" rating in a research note on Monday, August 31st. Seven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $125.88.
Check Out Our Latest Stock Analysis on Billiontoone
Billiontoone Company Profile
(
Get Free Report)
BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company's technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.
The company's primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
